Remineralization of caries lesions is naturally achieved by salivary ions, and it can be enhanced by external factors or elements such as fluoride. Numerous studies have demonstrated the remineralizing efficacy of fluoride therapies as well as the limitations with some groups of the population. Consequently, developing new remineralization therapies to close this gap in efficacy has been a priority for the last 2 decades. In this review, we summarize and briefly discuss some of the latest advances in remineralization therapies. Most new therapies try to enhance the effect of fluoride by adding other potentially active ingredients to the formulation, such as calcium, phosphate, stannous, xylitol, and arginine. Other remineralization strategies have focused on creating remineralizing scaffolds within the lesions (e.g., self-assembling peptides). While several of the new remineralization strategies have progressed significantly in recent years, for most of them, the evidence is still insufficient to assess their true clinical potential.
Introduction
Dental remineralization is the process of bringing minerals from the surrounding environment (i.e., saliva, biofilm) into partially demineralized tooth structures. Remineralization can replace minerals in partially demineralized enamel and dentin (Cochrane et al. 2010) or create amorphous mineral precipitates in the intercrystal and interrod spaces. Remineralization can occur naturally or be induced by therapies. Among the available therapies, fluoride (F)-based treatments have the highest level of supporting evidence (Amaechi and van Loveren 2013; Fontana 2016) , and the widespread use of fluorides is generally considered the main reason for dental caries reduction in most populations. However, currently available F therapies have limited efficacy in some individuals, and at the population level, the effect of F in reducing dental caries prevalence is reaching a plateau (Haugejorden and Magne Birkeland 2006) . Consequently, investigators have been developing new remineralization therapies to close this gap in efficacy. Most new approaches have been designed to enhance the effect of existing F therapies rather than to replace them, but those not involving F might become an alternative for patients reluctant to use F. In this article, we discuss and summarize some of the latest advances in remineralization therapies.
Information Search
Advances in remineralizing therapies were identified after a broad literature search by using the following terms: remineralization, arrest, arrestment, repair, treatment and caries lesion, dental caries, enamel or dentin. PubMed was used to identify published data and other sources, while ClinicalTrials.gov and google.com were used to obtain registered randomized controlled trials (RCTs). We prioritized evidence published during the last 5 y. Therapies that only targeted the modification of dental biofilms (e.g., antimicrobials, probiotics, ozone) or created diffusion barriers (e.g., sealants, infiltrants) were excluded, since they do not promote remineralization directly. Antimicrobial therapies combined with other remineralizing therapies (e.g., arginine plus F and calcium) were included in this review. Therapies focused on preventing lesion formation only (not remineralization) were also excluded. Therapies were classified regarding their general putative mechanism of action. For each therapy, we summarized the most recent available evidence derived from clinical trials. If recent RCTs were not available, the latest available evidence is presented (in situ or in vitro).
Compounds Increasing Mineral Saturation
Calcium and phosphate are essential minerals for remineralization, while F plays a crucial role in enhancing the process. Because remineralization can be hampered by limited bioavailability of calcium and phosphate, new product formulations designed to ensure a constant supply of calcium and phosphate have been developed (Cochrane et al. 2010) . The following remineralization therapies were designed to directly increase mineral concentration in the environment around caries lesions (in saliva or biofilm).
Fluorides. F treatment is still the standard therapy for remineralization of caries lesions (Amaechi and van Loveren 2013; Fontana 2016) . Diverse F therapies have been shown to be clinically effective in arresting caries lesions, and a dose response has been demonstrated for F toothpastes (Walsh et al. 2010 ). Toothpastes at 5000-ppm F are more efficacious for remineralizing root caries lesions than those at 1000-to 1500-ppm F (Wierichs and Meyer-Lueckel 2015) ; however, the evidence demonstrating their superior benefit for remineralizing enamel lesions is still limited. Therefore, recommending them to patients with active lesions should not be done indiscriminately, and their higher cost and limited availability should be considered as well (Amaechi and van Loveren 2013) . F products at high concentration, such as varnishes, provide effective remineralizing therapy for noncavitated enamel lesions in primary and permanent dentition (Lenzi et al. 2016) . F mouth rinses and high-concentration F gels have been shown to be effective in preventing lesion formation (Marinho et al. 2015; Marinho et al. 2016) , but evidence demonstrating their remineralizing ability is limited (Lenzi et al. 2016) . This lack of evidence concerning remineralization might reflect older studies that focused predominantly on the caries prevention abilities of F, the main putative mechanism of action at that time (Lenzi et al. 2016) .
Combination of some metals with F could enhance the antimicrobial effect of the therapy. For example, silver diamine F (SDF) has been shown to be highly effective for remineralizing caries lesions in coronal (Gao et al. 2016 ) and root surface (Wierichs and Meyer-Lueckel 2015) dentin. More recently, SDF has been studied for its remineralization potential in early enamel lesions in approximal and occlusal surfaces (MattosSilveira et al. 2014; NCT02789202) . Additional RCTs are currently being conducted to evaluate SDF (NCT02536040, NCT02601833, NCT02742142, NCT02360124). If the results of these trials concur with previous results, SDF therapy could soon become the remineralization therapy with the highest level of evidence supporting its efficacy. Since SDF is not available in some countries, silver nitrate (AgNO 3 ) has been suggested as an alternative. A recent RCT compared the efficacy of 25% AgNO 3 , followed by 5% NaF varnish, in arresting early childhood caries lesions (Chu et al. 2015) . Both SDF and AgNO 3 will stain the remineralized tissue black or dark brown-the most significant drawback of these therapies.
Another example of metal association with F that has generated renewed interest in dental caries management is stannous F (SnF 2 ), which has the potential to interfere with biofilm formation and simultaneously affect the demineralization/remineralization process. Numerous laboratory studies have demonstrated the antimicrobial properties of tin ions (partially reviewed by Fernández et al. 2016) . Recent laboratory data suggest that current SnF 2 formulations have a superior anticaries effect (by preventing enamel demineralization) in the presence of cariogenic biofilms (Fernández et al. 2016) . Tin also seems to provide acid resistance by precipitating on the tooth surface and creating a diffusion barrier, but to some extent this barrier might also interfere with remineralization (Lippert 2016) . Complete understanding on the mechanism of action of SnF 2 remains elusive.
The following therapies are the most relevant calcium and phosphate-based systems available today. Details of their classification and mechanism of action have been previously reviewed (Cochrane et al. 2010 ). Phosphate (Recaldent) . CPP-ACP is a stabilized system of calcium and phosphate that has been considerably studied the last 20 y. Several literature and systematic reviews of its anticaries effect have been published (Azarpazhooh and Limeback 2008; Reynolds 2009; Zero 2009; Li et al. 2014) . While most have shown a significant remineralizing effect, the reviews have raised concerns with the lack of independent studies (Azarpazhooh and Limeback 2008; Zero 2009 ) and the excessive use of shortterm in situ models, which have limited clinical translatability of the results (Zero 2009 ). Additionally, most remineralization studies have been conducted on orthodontics-related incipient lesions, thus limiting the generalizability of the results to other locations. Recent studies conducted by other research groups have shown the CPP-ACP remineralization potential on nonorthodontics lesions, with lesion fluorescence changes as the main outcome. These trials were ≤6 mo and used F varnish (Llena et al. 2015; Guclu et al. 2016) or a placebo (Sitthisettapong et al. 2015) as the control. However, no superiority of CPP-ACP over placebo tooth mousse was recently reported over a 1-y clinical study, most likely due to daily F toothpaste use by both study groups (Sitthisettapong et al. 2015) . Because of conflicting results, the short duration of the trials, and the dominance of only fluorescence changes in lesions after orthodontics as the outcome, the conclusions stated in recent reviews Fontana 2016 ) are still valid. Better clinical evidence is still needed to demonstrate that the CPP-ACP therapy is not inferior to F therapies.
CPP-ACP: Casein Phosphopeptide-Amorphous Calcium

CPP-ACPF:
Casein Phosphopeptide-Amorphous Calcium Phosphate Fluoride. F has been added to the CCP-ACP formulation to increase its remineralization efficacy. This modification in the formula, however, has not been shown to be more effective than CPP-ACP alone, as reported in a recent systematic review (Raphael and Blinkhorn 2015) . The latest reports have shown conflicting results. A recent study found that CPP-ACPF did not provide additional benefit in the remineralization of postorthodontic white-spot lesions (Singh et al. 2016) . Another short-term clinical study found that CPP-ACPF was not more effective than regular home care therapy (Huang et al. 2013) . CPP-ACPF appeared to have a specific remineralizing effect on smooth surface caries lesions but not on pit and fissure lesions (Llena et al. 2015) , while another study showed that CPP-ACPF was more effective than a NaF control in remineralizing incipient caries lesions (Juárez-López et al. 2014 ). In summary, there is not enough evidence to support that adding F to CPP-ACP increases its efficacy.
fTCP: Functionalized β-Tricalcium Phosphate. TCP is a crystalline system that was modified to produce a functionalized β-tricalcium phosphate (fTCP). This fTCP was designed to protect calcium from prematurely interacting with ionic F; thus, it can act as a low-dose delivering system (Karlinsey and Pfarrer 2012) . No recent clinical data evaluating its remineralization potential were found. However, there are ongoing clinical studies registered evaluating fTCP incorporated to varnish (NCT02341872) and high-concentration F toothpastes (NCT0 2136576). Phosphosilicate (NovaMin) . The potential for this bioactive glass material for remineralization was revised by Wefel (2009) and Burwell et al. (2009) a few years ago, with both concluding that the technology was promising but more research was needed. At the time of publication of those reviews, RCTs were in progress. For this current review, no published clinical data were found for remineralization, and the level of evidence of in vitro and in situ data is weak and controversial. For example, NovaMin was superior to CPP-ACP mousse in enhancing enamel remineralization in vitro (Wang et al. 2016) , but the addition of 5% CSPS to sodium monofluorophosphate toothpaste did not improve the remineralization of enamel specimens in situ (Parkinson et al. 2017) .
CSPS: Bioactive Glass Containing Calcium Sodium
TMP: Sodium Trimetaphosphate. TMP is a cyclic polyphosphate salt that adsorbs on the enamel surface. It was clinically studied in the 1990s and currently is being tested for its potential to enhance the effect of F. In situ data have shown that the supplementation of F varnishes (Manarelli et al. 2015) and gels (Danelon et al. 2013 ) with TMP leads to enhanced remineralization of artificial caries lesions. Another in situ study showed that TMP nanoparticles added to a 1100-ppm F NaF-containing toothpaste could increase its remineralization ability (Danelon et al. 2015) . Last, TMP added to low-F concentration toothpaste showed a remineralization ability similar to that of a toothpaste with standard F concentration in situ (Takeshita et al. 2016) . In situ data have clearly shown the potential of this technology; however, recommendation for clinical use should be done after these results have been confirmed in clinical trials.
Overall, products containing calcium phosphate-based systems have not shown consistent superiority to those with F, and they should not be recommended to replace the regular use of F products. Products containing calcium phosphate-based systems and free of F might be indicated for patients reluctant to using F products or for young children at risk of dental fluorosis (Fontana 2016) .
Biofilm Modifiers
The following therapies were designed to enhance the remineralizing effect of F by affecting the amount, composition, and metabolic activity of the dental biofilm around caries lesions.
Arginine. Numerous studies have shown that the amino acid arginine can affect the pH and ecology of oral biofilms. Consequently, it was introduced to toothpaste (1.5% arginine) with insoluble calcium and 1,450-ppm F (as sodium monofluorophosphate) to enhance caries lesion prevention through greater remineralization. This potential effect on biofilm pH would supplement mechanical plaque control, helping to maintain biofilm homeostasis with the host (Cummins 2016) .
Several randomized clinical studies (5 for remineralization and 3 for caries lesions prevention) were conducted showing consistent superior results for the arginine+F+Ca formulation when compared with nonarginine formulations. Three of the remineralization studies were conducted in naturally occurring enamel caries lesions at buccal surfaces of maxillary incisors, and measured by quantitative light-induced fluorescence (QLF; Srisilapanan et al. 2013; . The other 2 studies evaluated the ability of the toothpaste to arrest and reverse root caries lesions Souza et al. 2013) , with hardness as a clinical indicator for lesion activity.
A recent systematic review and meta-analysis concluded that this formulation potentially offers a superior anticaries effect . A different systematic review concluded that the available evidence is insufficient to support the superior anticaries efficacy of arginine-containing toothpaste because of the high risk of commercial bias in the conducted studies (Astvaldsdottir et al. 2016) .
No new RCTs evaluating remineralization have been published since the last systematic reviews, and other registered ongoing trials were not found. In summary, clinical trials have shown that this formulation has a clear potential to significantly boost the performance of toothpaste with F alone; however, final recommendations should be made after results have been confirmed in high-quality, long-term, and potentially less biased studies Astvaldsdottir et al. 2016; Fontana 2016) .
Triclosan. Triclosan is an antibacterial agent that could affect biofilm acid production that leads to higher saturation and therefore higher remineralization. Large studies conducted in the 1990s and 2000s showed that adding triclosan to the dentifrice formulation can produce modest but statistically significant reductions of coronal and root caries incidence in children and adults (Riley and Lamont 2013 ). An in situ study conducted in 2004 suggested that it might also have an effect in remineralization (Silva et al. 2004 ). More recently, triclosanloaded dendrimers are being studied as potential agents for remineralization (Zhou et al. 2014 ), but no clinical data of this new technology are available yet.
Xylitol. Xylitol is a naturally occurring sugar alcohol that has been shown to have antimicrobial and potentially anticaries effects (Riley et al. 2015) . Data on xylitol remineralization, however, are much scarcer. Different self-delivery therapies containing this artificial sweetener have been recently clinically tested. A sugar-free chewing gum containing 36% xylitol and 32% sorbitol was shown to be able to remineralize enamel lesions (QLF); unfortunately, there was no appropriate control to differentiate xylitol from the effect of chewing (Dong et al. 2014) . A recent in situ study showed its potential when introduced to varnishes at a 20% concentration (Cardoso et al. 2016) . In summary, while xylitol is a promising strategy, there is not enough evidence to fully assess its potential as a remineralizing agent.
Herbal Compounds
Several herbal or other natural compounds have been studied in vitro as remineralization therapies. Depending on the specific compound, they could affect mineral saturation and precipitation, act as antimicrobials, or stabilize collagen that could function as a scaffold for mineral deposition (Chandna et al. 2016) . Proanthocyanidins have been shown to possibly have a synergistic effect with calcium phosphate-based compounds when remineralizing artificial root caries lesions in vitro (Epasinghe et al. 2017 ). While they seem to be a promising option, future in situ and in vivo studies are necessary to confirm the in vitro findings.
Self-assembling Peptides
Because minerals from saliva or minerals supplied by other therapies need nucleation sites for precipitation and remineralization, a biomimetic technology was introduced about a decade ago to promote faster remineralization (Kirkham et al. 2007 ). Laboratory studies showed that monomeric low-viscosity peptide solutions can be introduced into enamel lesions to spontaneously create scaffolds capable of hydroxyapatite nucleation that promotes remineralization (Kirkham et al. 2007 ). Recent in vitro data showed the remineralization potential of the technology, as demonstrated in a variety of remineralization outcomes: visual inspection and scanning electron microscopy, QLF, photothermal radiometry and luminescence, microhardness, energy-dispersive x-ray spectroscopy analysis, and confocal laser scanning microscopy. Laboratory data also indicated that the self-assembling peptide P11-4 diffuses well into the body of the caries lesion, facilitating its remineralization by supporting nucleation of de novo hydroxyapatite (Kind et al. 2017) . One recent RCT demonstrated that this therapy is safe for human use (Alkilzy et al. 2017) . The results of this single-blind 6-mo study suggest that P11-4 in combination with F varnish (22,600-ppm F) is superior than F varnish alone on promoting remineralization of early carious lesions (Alkilzy et al. 2017) . Others RCTs are currently registered (NCT02101255, NCT02020681, NCT02119507, NCT02913885, NCT02341872). The study length of these trials spans 6 mo to 2 y and includes evaluation of the remineralization effect in different locations of caries lesions (approximal, buccal, and occlusal). Visual and radiographic examination, photographs, fluorescence, color, and patient satisfaction are some of the primary and secondary outcomes being assessed in those trials. Three of these trials are sponsored by the company developing this technology. Results from the ongoing clinical trials will be able to confirm the putative potential of the technology.
Conclusions
Several remineralizing strategies have significantly progressed in recent years. Most of these therapies prolong the supersaturation periods by creating stable systems capable of supplying bioavailable calcium, phosphate, and F directly to the lesion or to the surrounding biofilm. One significant challenge for remineralizing therapies is to provide the right concentration of minerals at the right time; elevated mineral concentration at the wrong time could lead to unwanted surface precipitation, thereby limiting the efficacy of the therapy. Slow and prolonged delivery of minerals might favor subsurface mineral gain. Other therapies attempt to modify environmental conditions around lesions (e.g., biofilm modifiers) or the structure of the body of the lesions (e.g., scaffolds). Last, a new iontophoresis technology designed to accelerate the flow of mineral ions into deeper areas of demineralized enamel was presented at the 2017 ICNARA meeting (International Conference on Novel Anticaries and Remineralizing Agents). Early results have shown promise (Pitts 2017) ; however, it is too early for a thorough evaluation of its remineralization potential.
Overall, the conduction of clinical trials to evaluate the efficacy and effectiveness of novel therapies should be a research priority. Studies should be conducted in different populations and by independent groups. It is of upmost importance to evaluate efficacy in lesions at different surfaces (e.g., occlusal, where most lesions develop) and with validated outcomes for remineralization. Last, we remark on the importance of clinical trial registration. Reduction of outcome reporting and publication bias is crucial in the validation of novel technologies.
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